Oral Anti-Diabetic Agents-Review and Updates
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 2
Abstract
Diabetes is a chronic metabolic disorder with high mortality rate and with defects in multiple biological systems. Two major types of diabetes are recognized, type 1 and 2 with type 2 diabetes (T2D) being by far the more prevalent type. As diabetes affects multiple biological functions, the use of multiple drug classes having different mode of actions is required in order to optimize therapy in diabetic patients. Five major classes of oral antidiabetic agents (OHA) have traditionally been used for the management of patients with T2D. These include the sulphonylureas, meglitinides, biguanides, thiazolidinediones and the alpha-glucosidase inhibitors. Several newer classes of agents have also been introduced recently in the pharmacotherapy of T2D, including the incretin mimetics, the dipeptidy peptidase 4 (DPP-4) inhibitors, the sodium glucose co-transporter 2 (SGLT 2) inhibitors and more recently, the dual peroxisome proliferator-activated receptor (PPAR) agonists. Each of these agents has been shown in various experimental and clinical settings to be efficacious in T2D, but each is also associated with a number of adverse effects. Despite the vast array of drugs introduced, metformin, a biguanide, largely remains the first choice mono therapy in T2D patients but several combination options are also available in poly pharmacy when mono therapy fails to produce the required glycemic control. The increasing number of drugs, together with numerous combination options in poly pharmacy, presents with the clinician an increasing complexity of therapeutic options. The likely pathogenetic mechanism of diabetes operating in the patient, as well as the mode of action, efficacy and safety of the drugs are some of the major considerations in the choice of any given agent or its combinations. This review therefore focuses on the mode of action, pharmacokinetics, indications, efficacy and adverse effects of the OHA used in T2D.
Authors and Affiliations
Patience O. Osadebe, Estella U. Odoh, Philip F. Uzor
Keywords
Related Articles
- EP ID EP348010
- DOI 10.9734/BJMMR/2015/8764
- Views 66
- Downloads 0
Antimicrobial Resistance Patterns of Escherichia coli Isolated from Urinary Tract Infections in the Midwestern United States
Aims: To determine the antimicrobial resistance of urinary tract infection isolates in a major metropolitan area for the purposes of tracking increases in resistance and to provide information that will help drive improv...
Clinical Characteristics and Management of Adnexal Torsion
Adnexal torsion is a gynaecologic surgical emergency. Misdiagnosis or delay may lead to loss of the adnexa and may compromise fertility. Aim: To determine the most relevant findings for the diagnosis of adnexal torsion a...
Some Haematological Parameters of Symptomatic and Asymptomatic Hepatitis B Positive Patients Attending a Nigerian Tertiary Hospital
Hepatitis B virus is a deadly viral infection that kills slowly if not treated and could be the underlying cause of liver cirrhosis and liver cancer. Some Hepatitis B positive patients may present with symptoms while som...
Emergency and Inpatient Treatment of Migraine: An American Headache Society Survey
Objective: To determine the medication and management preferences of headache specialists in treating migraine in the ED and during inpatient hospitalization. Background: Despite the frequency of migraine as a presenting...
Clinical and Imaging Findings of Symptomatic Right Aortic Arch and Double Aortic Arch: Case Report
Aim: Anomalies of aortic arch are uncommon, accounting for only 1-3% of all congenital cardiac diseases. A vascular ring results from the abnormal development of an aortic arch complex. Generally, it manifests with trach...